Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXS1NH
|
||||
| Drug Name |
N-((S)-1-((4S,7R)-7-methyl-3-oxo-1-picolinoylazepan-4-ylamino)-3-(1-methylcyclohexyl)-1-oxopropan-2-yl)furan-2-carboxamide
|
||||
| Synonyms |
CHEMBL1807703
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C28H36N4O5
|
||||
| Canonical SMILES |
C[C@@H]1CC[C@H](NC(=O)[C@H](CC2(C)CCCCC2)NC(=O)c3occc3)C(=O)CN1C(=O)c4ccccn4
|
||||
| InChI |
InChI=1S/C28H36N4O5/c1-19-11-12-20(23(33)18-32(19)27(36)21-9-4-7-15-29-21)30-25(34)22(17-28(2)13-5-3-6-14-28)31-26(35)24-10-8-16-37-24/h4,7-10,15-16,19-20,22H,3,5-6,11-14,17-18H2,1-2H3,(H,30,34)(H,31,35)/t19-,20+,22+/m1/s1
|
||||
| InChIKey |
POPLFVJHDAWIDM-URVUXULASA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.